MEDS — Meds Apotek AB Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesMicro Cap
- SEK541.69m
- SEK503.58m
- SEK1.01bn
Annual income statement for Meds Apotek AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 655 | 829 | 1,006 |
| Cost of Revenue | |||
| Gross Profit | 33.1 | 48.1 | 56.4 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 704 | 837 | 1,009 |
| Operating Profit | -49.1 | -8.15 | -2.41 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -51.5 | -11.1 | -3 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -51 | -10.4 | 7.73 |
| Net Income Before Extraordinary Items | |||
| Net Income | -51 | -10.4 | 7.73 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -51 | -10.4 | 7.73 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -3.05 | -0.603 | 0.416 |